Inactive Instrument

Onyx Pharmaceuticals, Inc. Stock

Stocks

End-of-day quote Nasdaq
- ^USD	-

27/08/13	Gilead Sciences, Inc. : Bradway's patient dealmaking brings Onyx to Amgen	RE
27/08/13	Onyx Pharmaceuticals, Inc. : Onyx deal expected to give Amgen a big boost	RE

27/08/13	Gilead Sciences, Inc. : Bradway's patient dealmaking brings Onyx to Amgen	RE
27/08/13	Onyx Pharmaceuticals, Inc. : Onyx deal expected to give Amgen a big boost	RE
27/08/13	Onyx Pharmaceuticals, Inc. : Onyx deal expected to give Amgen a big boost	RE
26/08/13	AstraZeneca plc : AstraZeneca to buy U.S. cancer firm for up to $500 million	RE
25/08/13	Pfizer Limited : Amgen close to buying Onyx for $125 per share: sources	RE
22/08/13	Amgen, Inc. : Exclusive: Onyx provides drug trial data to potential bidders - sources	RE
16/08/13	Onyx Pharmaceuticals, Inc. : Amgen seeks drug trial data before finalizing Onyx deal: sources	RE
08/08/13	Bank of America Corp : Amgen deal for Onyx possible within week - sources	RE
08/08/13	Bank of America Corp : Amgen deal for Onyx possible within week-sources	RE
19/07/13	Biogen Idec Inc : Exclusive: Pfizer not moving forward with Onyx bid: sources	RE
17/07/13	Ranbaxy Laboratories Limited : Novartis lifts full-year outlook after competition delay	RE
13/07/13	Pfizer Inc. : Roche seeks financing for potential Alexion bid -sources	RE
02/07/13	Insmed Incorporated : S&P 500 extends gains to year's second half on solid data	RE

02/10/15	Onyx Pharmaceuticals : Amgen Receives CHMP Positive Opinions for Two New Treatment Options for Patients with Blood Cancer in Europe	PU
24/07/15	Onyx Pharmaceuticals : Amgen Submits Supplemental New Drug Application for Kyprolis® (Carflizomib) in Relapsed Multiple Myeloma	PU
31/05/15	Onyx Pharmaceuticals : Amgen Initiates Phase 3 Study Evaluating Once-Weekly Kyprolis® (Carflizomib) in Patients with Relapsed and Refractory Multiple Myeloma	PU
28/05/15	Onyx Pharmaceuticals : Amgen to Advance Understanding of the Treatment of Blood Cancers at the 20th Congress of European Hematology Association (EHA)	PU
14/05/15	Onyx Pharmaceuticals : Amgen Data at ASCO 2015 Highlight Oncology Pipeline and Portfolio	PU

27/08/13	Onyx Pharmaceuticals, Inc. : Les propos de Kerry sur la Syrie font trébucher Wall St
26/08/13	Wall Street ouvre sans grand changement
26/08/13	Les valeurs à suivre aujourd'hui à Wall Street
26/08/13	USA-Les valeurs à suivre à Wall Street (actualisé)
26/08/13	Amgen, Inc. : s'offre le groupe pharmaceutique ONYX pour 10,4 milliards de dollars

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	-1.59%	-3.35%	+64.49%	+98.69%	70.64B
ARGENX SE	-1.34%	-0.75%	+48.56%	+90.63%	66.11B
BIONTECH SE	-8.37%	-12.43%	+0.14%	-15.42%	27.98B
INSMED INCORPORATED	-2.35%	-5.75%	-12.17%	+448.29%	26.51B
WUXI BIOLOGICS (CAYMAN) INC.	+0.30%	-0.69%	+63.18%	+11.93%	26.44B
PHARMAESSENTIA CORPORATION	-0.96%	+10.36%	+278.86%	+438.78%	20.4B
GENMAB A/S	-0.51%	+0.23%	+33.71%	-18.02%	20.17B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-1.91%	-4.37%	+13.33%	+531.29%	15.99B
EXELIXIS, INC.	-1.47%	+0.68%	+43.67%	+145.49%	13.69B
Average	-2.02%	+0.19%	+59.31%	+192.41%	31.99B
Weighted average by Cap.	-1.98%	+0.11%	+56.60%	+152.15%

Employees

Sector